UA75807U - Method for preventing metabolic disorders of bone tissue associated with non-natural ration and effects of tuberculostatics - Google Patents

Method for preventing metabolic disorders of bone tissue associated with non-natural ration and effects of tuberculostatics

Info

Publication number
UA75807U
UA75807U UAU201207567U UAU201207567U UA75807U UA 75807 U UA75807 U UA 75807U UA U201207567 U UAU201207567 U UA U201207567U UA U201207567 U UAU201207567 U UA U201207567U UA 75807 U UA75807 U UA 75807U
Authority
UA
Ukraine
Prior art keywords
tuberculostatics
ration
natural
effects
bone tissue
Prior art date
Application number
UAU201207567U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Юрій Анатолійович Калініченко
Юрий Анатольевич Калиниченко
Тамара Анатоліївна Сіротченко
Тамара Анатольевна Сиротченко
Ольга Анатоліївна Макаренко
Ольга Анатольевна Макаренко
Євген Дмитрович Андросов
Евгений Дмитриевич Андросов
Original Assignee
Юрій Анатолійович Калініченко
Юрий Анатольевич Калиниченко
Тамара Анатоліївна Сіротченко
Тамара Анатольевна Сиротченко
Ольга Анатоліївна Макаренко
Ольга Анатольевна Макаренко
Євген Дмитрович Андросов
Евгений Дмитриевич Андросов
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Юрій Анатолійович Калініченко, Юрий Анатольевич Калиниченко, Тамара Анатоліївна Сіротченко, Тамара Анатольевна Сиротченко, Ольга Анатоліївна Макаренко, Ольга Анатольевна Макаренко, Євген Дмитрович Андросов, Евгений Дмитриевич Андросов filed Critical Юрій Анатолійович Калініченко
Priority to UAU201207567U priority Critical patent/UA75807U/en
Publication of UA75807U publication Critical patent/UA75807U/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A method for preventing the metabolic disorders of the bone tissue associated with non-natural ration and effects of tuberculostatics provides for oral administration of lecithin D3 to the rats in the form of the aqueous suspension at a dose of 500 mg of the composition per 1 kg of body mass once a day on an empty stomach for two months.
UAU201207567U 2012-06-20 2012-06-20 Method for preventing metabolic disorders of bone tissue associated with non-natural ration and effects of tuberculostatics UA75807U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201207567U UA75807U (en) 2012-06-20 2012-06-20 Method for preventing metabolic disorders of bone tissue associated with non-natural ration and effects of tuberculostatics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201207567U UA75807U (en) 2012-06-20 2012-06-20 Method for preventing metabolic disorders of bone tissue associated with non-natural ration and effects of tuberculostatics

Publications (1)

Publication Number Publication Date
UA75807U true UA75807U (en) 2012-12-10

Family

ID=74307565

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201207567U UA75807U (en) 2012-06-20 2012-06-20 Method for preventing metabolic disorders of bone tissue associated with non-natural ration and effects of tuberculostatics

Country Status (1)

Country Link
UA (1) UA75807U (en)

Similar Documents

Publication Publication Date Title
PH12015502691A1 (en) Use of high dose pridopidine for treating huntington's disease
EP3904502A3 (en) Compositions and methods
UA115139C2 (en) Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
EA201690107A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYLFUMATE FOR INTRODUCTION TO LOW DAILY DOSE
MX2015002378A (en) Anxiolytic composition, formulation and method of use.
BR112014003414A2 (en) method of producing physiological and therapeutic levels of nitric oxide through an oral delivery system
MY173215A (en) Acetylcysteine compositions and methods of use thereof
PH12014502447A1 (en) Use of high dose laquinimod for treating multiple sclerosis
TN2012000566A1 (en) Dry powder formulation comprising an antimuscarinic drug
MX2017016801A (en) Drospirenone-based contraceptive for a female patient affected with excess weight.
IN2015DN03921A (en)
MY171048A (en) Pharmaceutical composition for preventing or treating amyloid beta peptide-associated diseases or conditions
WO2011019735A3 (en) Nutritional supplements
MX2016008027A (en) Use of laquinimod to delay huntington's disease progression.
MX2015009891A (en) Pharmaceutical compositions comprising multi-component crystalline particles suitable for use in inhalation therapy.
MX2013013098A (en) Methods and compositions for promoting lean body mass growth.
EP3954360A3 (en) Pharmaceutical preparation of carbohydrates for therapeutic use
UA75807U (en) Method for preventing metabolic disorders of bone tissue associated with non-natural ration and effects of tuberculostatics
NZ595798A (en) Ectoparasiticidal methods and formulations
NZ597675A (en) Medicament for the long term nsaid use
WO2012134590A3 (en) Calcium supplement
TW201613606A (en) Therapeutic drug for chronic renal failure
MX2015006217A (en) Dispersible tablet.
MX2016006375A (en) A combination of dosage units for use in the treatment of pre-term labour condition.
UA74544U (en) method for treatment and prevention of chronic generalized periodontitis